Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res. 2021 Jul 1;27(13):3630-3640. doi: 10.1158/1078-0432.CCR-20-4792. Epub 2021 Apr 5.
Clin Cancer Res. 2021.
PMID: 33820783
Clinical Trial.
Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
Evans EE, Jonason AS Jr, Bussler H, Torno S, Veeraraghavan J, Reilly C, Doherty MA, Seils J, Winter LA, Mallow C, Kirk R, Howell A, Giralico S, Scrivens M, Klimatcheva K, Fisher TL, Bowers WJ, Paris M, Smith ES, Zauderer M.
Evans EE, et al.
Cancer Immunol Res. 2015 Jun;3(6):689-701. doi: 10.1158/2326-6066.CIR-14-0171. Epub 2015 Jan 22.
Cancer Immunol Res. 2015.
PMID: 25614511
Item in Clipboard
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
Smith ES, Jonason A, Reilly C, Veeraraghavan J, Fisher T, Doherty M, Klimatcheva E, Mallow C, Cornelius C, Leonard JE, Marchi N, Janigro D, Argaw AT, Pham T, Seils J, Bussler H, Torno S, Kirk R, Howell A, Evans EE, Paris M, Bowers WJ, John G, Zauderer M.
Smith ES, et al.
Neurobiol Dis. 2015 Jan;73:254-68. doi: 10.1016/j.nbd.2014.10.008. Epub 2014 Oct 18.
Neurobiol Dis. 2015.
PMID: 25461192
Free article.
Item in Clipboard
Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity.
Evans EE, Mishra V, Mallow C, Gersz EM, Balch L, Howell A, Reilly C, Smith ES, Fisher TL, Zauderer M.
Evans EE, et al.
J Neuroinflammation. 2022 Aug 6;19(1):200. doi: 10.1186/s12974-022-02509-8.
J Neuroinflammation. 2022.
PMID: 35933420
Free PMC article.
Item in Clipboard
CXCL13 antibody for the treatment of autoimmune disorders.
Klimatcheva E, Pandina T, Reilly C, Torno S, Bussler H, Scrivens M, Jonason A, Mallow C, Doherty M, Paris M, Smith ES, Zauderer M.
Klimatcheva E, et al.
BMC Immunol. 2015 Feb 12;16(1):6. doi: 10.1186/s12865-015-0068-1.
BMC Immunol. 2015.
PMID: 25879435
Free PMC article.
Item in Clipboard
Cite
Cite